First biomedical research institute in Luxembourg, ranked amongst the leading non-academic institutions in the world by the Times Higher Education in 2018, the Luxembourg institute of Health aims at performing transversal translational research that transcends the boundaries of classical disease definition by putting a particular focus on inflammation related disease development.
Over the last years, LIH has been repositioning from fundamental research to encompass a more patient-centered translational dimension. Well integrated in Luxembourg’s biomedical landscape, LIH has numerous and intensive collaborations with hospitals in Luxembourg, the Luxembourg Centre for System Biomedicine (LCSB) and prestigious international partners.
It gathers around 45 scientific research groups and scientific platforms working in the fields of cancer, immunological disorders, neurodegenerative diseases and preventive medicine.
To discover more on LIH research, browse our research groups, scientists or priority research topics: cancer, immunological disorders, neurodegenerative diseases and preventive medicine.